AlphaNavi Pharma Inc.
AlphaNavi Pharma is developing a unique voltage-gated sodium channel inhibitor for neuropathic pain.
4 employees · est. 2019 · Suita, Japan
Vectus Biosystems
Vectus Biosystems (ASX:VBS) is developing a treatment for fibrosis and high blood pressure.
4 employees · est. 2005 · Australia
Vectus Biosystems is the older company (2019 vs 2005).
Side-by-Side Comparison
| Metric | AlphaNavi Pharma Inc. | Vectus Biosystems |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2005 older |
| Headquarters | ||
| Headquarters | Suita, Japan | Australia |
| Employees | ||
| Employees | 4 | 4 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series A | Not tracked yet |
| Total Funding | ||
| Total Funding | $900.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 1 | Not tracked yet |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Pharmaceuticals, Neuropathic Pain, Analgesic Drug, Sodium Channel Inhibitor, Clinical Development, Pain Management, Rare Pain Diseases, Precision Medicine, Phase 1/2 Study, Out-licensing, Academic Collaboration, Investor Collaboration | Pharmaceuticals, Fibrosis Treatment, Hypertension Treatment, IPO, ASX Listing, Pre-clinical Trials, Drug Development, Toxicity Studies, Commercialisation, DNA And RNA Measurement Technology, Accugen, Lab Testing, Scientific Discovery, Metabolic Research |
| Website | ||
| Website | alphanavi.com | vectusbiosystems.com.au |
About AlphaNavi Pharma Inc.
AlphaNavi Pharma Inc. is a biotechnology startup based in Japan, founded in 2019. The company is focused on developing a unique voltage-gated sodium channel inhibitor, ANP-230, for the treatment of neuropathic pain, particularly targeting Nav1.7, Nav1.8, and Nav1.9. This compound is also aimed at ad...
About Vectus Biosystems
Vectus Biosystems (ASX:VBS) is a biotechnology startup based in Australia that focuses on developing treatments for fibrosis and high blood pressure. The company completed its Initial Public Offering (IPO) on the Australian Securities Exchange (ASX:VBS) in February 2016, raising A$5.1 million. The f...
We will tell you when either one moves
BounceWatch watches AlphaNavi Pharma Inc. and Vectus Biosystems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at AlphaNavi Pharma Inc. and Vectus Biosystems — by email.
Frequently Asked Questions
Compare AlphaNavi Pharma Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at AlphaNavi Pharma Inc. on 11 Sep 2024, and Vectus Biosystems on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.